Skip to main content

Table 1 BRCA2 and CDKN2A mutations and corresponding variant allele fractions

From: Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report

Gene

Protein

Coding change

Variant allele fraction %

BRCA2

N1910fs*2

5727_5728insG

83.7

BRCA2

A1843_S1985del

5528_5956del429

0.53

BRCA2

A1891_M1936del

5671_5808del138

0.54

BRCA2

D1909_D1911 > EDY

5727_5731TAATG > AGACT

0.64

BRCA2

D1909_E1912 > V

5726_5735ATAATGATGA > T

0.13

BRCA2

I1664_V2049del

4989_6146del1158

0.18

BRCA2

I1903_D1909 > M

5709_5727TCTTCATAACTCTCTAGAT > G

0.11

BRCA2

L1908_N1910del

5722_5730delCTAGATAAT

0.33

BRCA2

L1908_S1917del

5721_5750del30

1.8

BRCA2

N1766_Q2009del

5292_6025 > CA

1.3

BRCA2

N1910_D1911del

5728_5733delAATGAT

3.3

BRCA2

S1788_P2114 > DTT

5362_6340 > GATACCA

1.2

BRCA2

Unknown

splice site 5333_6841 + 197del1706

4.8

CDKN2A

P114L

341C > T

10.0